Dr. Scolding trained in medicine in Cardiff and in clinical neurology in Cardiff, Cambridge (Addenbrooke’s) and London (National Hospital for Neurology). He was a consultant lecturer in Cambridge before going to Bristol in 1999 as foundation chairholder of the Burden Professorship of Clinical Neurosciences. His clinical interests and research center on clinical and biological aspects of multiple sclerosis and related inflammatory diseases and on developing adult stem cell repair treatments for multiple sclerosis and other neurodegenerative conditions. He has published over 200 research papers and three neurology textbooks, and has written in the lay press on assisted suicide, euthanasia, and human embryo research. He is currently a member of the Medical Research Council Neurosciences Panel, a guarantor of the neurology journal, Brain, and a member of the editorial board of several other journals. He is a member of Council of the Association of British Neurologists and has served in the past as secretary of the United Kingdom Neurology Specialty Advisory Committee of the Royal College of Physians/Joint Committee for Higher Medical Training, and executive committee member of the European Council for Treatment and Research in Multiple Sclerosis. He is a former chairman of the Governing Board of the Linacre Centre for Healthcare Ethics.
VATICAN CITY, June 16, 2011 — NeoStem, Inc. (“NeoStem” or the “Company”) (NYSE Amex: NBS), an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units – U.S. adult stem … Continue reading →
Opening ceremony featuring Church officials
Expert presentation on the state of adult stem cell science
Interactive discussions on the scientific, cultural and ethical implications
Breakout sessions to formulate action steps within geographic regions
Unprecedented exposure through Vatican media collaborations